8-K: 22nd Century Group Achieves Debt-Free Balance Sheet

22nd Century Group, Inc. announced the full repayment of its $3.9 million senior secured debt, achieving a debt-free balance sheet and securing new growth capital.

Summary

• 22nd Century Group, Inc. (XXII) fully repaid all outstanding obligations under its Senior Secured Credit Facility, including the Securities Purchase Agreement (JGB SPA) and related debentures.
• The company made aggregate payments totaling $3.9 million between August 29, 2025, and September 18, 2025, to settle the debt.
• All liens and security interests securing the debentures and related obligations were released upon repayment.
• The termination of the JGB SPA, Debentures, and related security documents occurred prior to their stated maturity.
• The company has eliminated greater than $20 million in senior secured and subordinated debt since CEO Larry Firestone joined the team.
• The completion of a Series A convertible preferred stock offering and the senior secured debt repayment resulted in an approximate $9.1 million increase in as adjusted pro forma net tangible book value, or approximately $1.05 per share.

Sentiment

Score: 9

Explanation: The filing indicates a strong positive financial event, with the company achieving a debt-free balance sheet, significantly reducing liabilities, and securing capital for future growth. This marks a major de-risking event and strategic pivot towards growth, enhancing the company's financial stability and operational flexibility.

Positives

• Achieved a debt-free balance sheet, eliminating ongoing cash interest and amortization expenses.
• Reduced ongoing cash needs and operating costs significantly by removing debt obligations.
• Increased as adjusted pro forma net tangible book value by approximately $9.1 million, or $1.05 per share.
• Secured working capital to support the purchase of low nicotine leaf crop for the production of more than 1 million cartons of VLN products.
• Positioned for growth with resources focused on expected margin expansion from branded products that began shipping in Q3 2025.
• Successfully eliminated over $20 million in senior secured and subordinated debt since the current CEO joined.

Risks

• The filing references important factors that could cause actual results to differ materially, as set forth in the Company's Annual Report on Form 10-K filed on March 20, 2025, and Quarterly Reports on Form 10-Q on May 13, 2025, and August 14, 2025. Specific risks are not detailed within this filing.

Future Outlook

Management plans to deploy a portion of capital to expand its very low nicotine tobacco leaf inventory in the fourth quarter of 2025, with inventory reserves allowing for production of more than one million cartons of VLN combustible products. The company anticipates margin expansion from branded products, which began shipping in Q3 2025, and is setting up its growth strategy into 2026 with plans for further adoption of partner VLN and additional branded product SKUs. The company is focused on utilizing its strong IP portfolio and resources to drive continuous expansion of its VLN reduced nicotine content products with partners.

Management Comments

• "We are pleased to remove one of the last legacy liabilities from the previous 22nd Century organization."
• "This is a huge step forward for the company, having now eliminated greater than $20 million in senior secured and subordinated debt since I joined the team."
• "With a debt-free balance sheet, we see a significant opportunity to use our resources in a forward-looking manner focused on growth, driven by the expected margin expansion from branded products which have begun shipping in Q3 2025."
• "Our plans for further adoption of partner VLN as well as additional branded product SKUs are setting up our growth strategy into 2026."

Industry Context

22nd Century Group is a pioneer in the tobacco harm reduction movement, utilizing proprietary non-GMO reduced nicotine tobacco plants. Its flagship VLN cigarette, containing 95% less nicotine, is the only low nicotine combustible cigarette authorized by the FDA in the United States, positioning the company uniquely in the evolving tobacco market focused on reduced harm products.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results for a direct assessment against global benchmarks. The company's unique position with FDA-authorized reduced nicotine content (RNC) tobacco products makes direct comparisons challenging without further industry-specific data.

Stakeholder Impact

• Shareholders: Benefit from a stronger balance sheet, reduced financial risk, increased net tangible book value, and a clearer path to growth and profitability.
• Creditors: The previous creditors (JGB Partners, LP, JGB Capital, LP, JGB Capital Offshore Ltd., and JGB Collateral, LLC) have been fully repaid and their liens released, concluding their financial relationship.
• Customers: Potential for increased availability and variety of VLN products due to expanded inventory and new SKUs, supporting the company's harm reduction mission.

Next Steps

• Deploy a portion of capital to expand very low nicotine tobacco leaf inventory in Q4 2025.
• Continue production of more than 1 million cartons of VLN combustible products.
• Further adoption of partner VLN products.
• Introduction of additional branded product SKUs.
• Drive continuous expansion of VLN reduced nicotine content products with partners into 2026.

Key Dates

Recommendation

The company has achieved a significant financial milestone by becoming debt-free, eliminating substantial legacy liabilities, and securing new growth capital. This dramatically de-risks the balance sheet, reduces ongoing cash burn from interest payments, and frees up resources for strategic growth initiatives in its unique FDA-authorized reduced nicotine product segment. The increase in net tangible book value and clear forward-looking growth plans, including inventory expansion and new product rollouts, suggest a strong positive trajectory for the company, making it an attractive investment for long-term growth.

Keywords

22nd Century Group, XXII, Debt Repayment, Senior Secured Debt, Balance Sheet, VLN, Tobacco Harm Reduction, FDA Authorized, Convertible Preferred Stock, Capital Raise, Financial Health